Expression of Molecular Markers in the Tumor and Survival Prognosis in Osteosarcoma-Reference-Cited by-同舟云学术

Expression of Molecular Markers in the Tumor and Survival Prognosis in Osteosarcoma

Published:2010-12 Issue:2 Volume:150 Page:237-242
ISSN:0007-4888
Container-title:Bulletin of Experimental Biology and Medicine
language:en
Short-container-title:Bull Exp Biol Med

Author:

Boulytcheva I. V.,Soloviev Yu. N.,Kushlinskii N. E.,Mahson A. N.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10517-010-1114-x.pdf

Reference15 articles.

1. G. I. Abelev and T. L. Eraizer, Biokhimiya, 73, No. 5, 605-618 (2008).

2. N. V. Zhukov and S. A. Tyulyandin, Ibid., 751-768 (2008).

3. E. N. Imyanitov and K. P. Khanson, Molecular Oncology: Clinical Aspects [in Russian], St. Petersburg (2007).

4. Manual of Immunohistochemical Diagnosis of Human Tumors, Eds. S. V. Petrov and N. T. Raikhlin [in Russian], 3rd ed., Kazan (2004).

5. G. A. Frank, L. E. Zavalishina, and Yu. Yu. Andreeva, Precise Diagnosis of Cancer by Immunohistochemical Evaluation of Markers [in Russian], Moscow (2009).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model;Cells;2023-03-16

2. A Multiparametric Method Based on Clinical and CT-Based Radiomics to Predict the Expression of p53 and VEGF in Patients With Spinal Giant Cell Tumor of Bone;Frontiers in Oncology;2022-06-21

3. Introducing Fluorescence-Guided Surgery for Pediatric Ewing, Osteo-, and Rhabdomyosarcomas: A Literature Review;Biomedicines;2021-10-04

4. Identification of Abnormal Spindle Microtubule Assembly as a Promising Therapeutic Target for Osteosarcoma;Orthopaedic Surgery;2020-10-20

5. APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion;Anti-Cancer Drugs;2019-10